Search Results - "Pugliese, Pascal"

To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?.

Authors: Ollier, Laurence Monte, Anne De Thibault, Vincent et al.

Source: Open Forum Infectious Diseases. Jun2025, Vol. 12 Issue 6, p1-4. 4p.

Facilitating the access to HIV testing at lower costs: "To the laboratory without prescription" (ALSO), a pilot intervention to expand HIV testing through medical laboratories in France.

Authors: Champenois, Karen Sawras, Victoire Ngoh, Pamela et al.

Source: PLoS ONE. 10/24/2024, Vol. 19 Issue 10, p1-18. 18p.

Impact of age on care pathways of people living with HIV followed up in hospital.

Authors: Jacomet, Christine Berland, Pauline Guiguet, Marguerite et al.

Source: AIDS Care. Jan2017, Vol. 29 Issue 1, p105-111. 7p. 4 Charts.

Subjects: HIV infections, Therapeutics, Age distribution, Chi-squared test, Confidence intervals, Fisher exact test, HIV-positive persons, Patient aftercare, Outpatient services in hospitals, Insurance, Medical cooperation, Medical protocols, Medical referrals, Medical specialties & specialists, Probability theory, Questionnaires, Research, Research funding, Self-evaluation, T-test (Statistics), Comorbidity, Disclosure, Socioeconomic factors, Refusal to treat, Cross-sectional method, Data analysis software, Descriptive statistics, Odds ratio, Mixed infections

Geographic Terms: France

Hepatitis C treatment initiation in HIV-HCV coinfected patients.

Authors: Cotte, Laurent Pugliese, Pascal Valantin, Marc-Antoine et al.

Source: BMC Infectious Diseases. 7/22/2016, Vol. 16, p1-9. 9p. 2 Charts, 3 Graphs.

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.

Authors: Rojas Rojas, Teresa Poizot-Martin, Isabelle Rey, David et al.

Source: PLoS ONE. 3/25/2022, Vol. 17 Issue 3, p1-15. 15p.

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

Authors: Cuzin, Lise Pugliese, Pascal Allavena, Clotilde et al.

Source: PLoS ONE. 12/07/2017, Vol. 12 Issue 12, p1-13. 13p.

Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort.

Authors: Poizot-Martin, Isabelle Lions, Caroline Allavena, Clotilde et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Mar2021, Vol. 30 Issue 3, p554-563.

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat'AIDS cohort.

Authors: Lemmet, Thomas Cotte, Laurent Allavena, Clotilde et al.

Source: PLoS ONE. 5/19/2022, Vol. 17 Issue 5, p1-15. 15p.

Incidences and risk factors of first-line HAART discontinuation: a limitation to the success of the “seek, test, treat, and retain” strategy?

Authors: Keita, Momory Perbost, Isabelle Pugliese-Wehrlen, Sylvia et al.

Source: AIDS Care. Aug2014, Vol. 26 Issue 8, p1058-1069. 12p.

Subjects: HIV infection risk factors, HIV infection epidemiology, Confidence intervals, HIV infections, Longitudinal method, Multivariate analysis, Regression analysis, Research funding, Viral load, Body mass index, Highly active antiretroviral therapy, Disease incidence, Proportional hazards models, Data analysis software, Descriptive statistics, CD4 lymphocyte count

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.

Authors: Allavena, Clotilde Flandre, Philippe Pugliese, Pascal et al.

Source: Scandinavian Journal of Infectious Diseases. 2012, Vol. 44 Issue 1, p37-43. 7p. 3 Charts.

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.

Authors: Allavena, Clotilde Katlama, Christine Cotte, Laurent et al.

Source: Infectious Diseases. May2016, Vol. 48 Issue 5, p392-398. 7p. 3 Charts, 1 Graph.

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

Authors: Virlogeux, Victor Zoulim, Fabien Pugliese, Pascal et al.

Source: BMC Medicine. 12/18/2017, Vol. 15, p1-11. 11p. 1 Diagram, 2 Charts, 2 Graphs.

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.

Authors: Cotte, Laurent Ferry, Tristan Pugliese, Pascal et al.

Source: PLoS ONE. 2/2/2017, Vol. 12 Issue 2, p1-12. 12p.

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

Authors: Allavena, Clotilde Hanf, Matthieu Rey, David et al.

Source: PLoS ONE. 9/21/2018, Vol. 13 Issue 9, p1-11. 11p.

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.

Authors: Gantner, Pierre Bani-Sadr, Firouze Garraffo, Rodolphe et al.

Source: PLoS ONE. 10/31/2016, Vol. 11 Issue 10, p1-13. 13p.

Clinical characteristics and outcome of HIV infected patients with chronic kidney disease in Sub Saharan Africa: an example from in Cameroon.

Authors: Halle MP Essomba N Djantio H et al.

Source: BMC nephrology [BMC Nephrol] 2019 Jul 09; Vol. 20 (1), pp. 253. Date of Electronic Publication: 2019 Jul 09.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE